📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-17 18:09
666 analysed today
666
Today
133,555
All-time analysed
40,122
Positive
6,284
Negative
79,331
Neutral
7,750
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
6 announcements match the current filters (relevance ≥ 5).
Transchem Acquires 100% of Greshma Shares & Stocks for ₹25.91 Cr
Transchem Limited has executed a Share Purchase Agreement to acquire 100% equity (1,55,16,000 shares) in Greshma Shares and Stocks Limited (GSSL) for an all-cash consideration of ₹25.91 Cr (₹16.70 per share). GSSL is a SEBI-registered stock broker and CDSL depository participant with an annual turnover of ₹5.98 Cr and a net worth of ₹21.32 Cr as of March 31, 2026. The acquisition marks Transchem's strategic diversification into capital markets and financial services, utilizing ~30.8% of its ₹84 Cr net worth. All regulatory approvals from SEBI, NSE, BSE, CDSL, NCL, and ICCL have been secured, and the transaction is effective August 17, 2026.
Confidence: HIGH
What changedTranschem has completed the 100% acquisition of Greshma Shares and Stocks Limited, making it a wholly-owned subsidiary.
Why it mattersProvides Transchem with an operational foothold and immediate revenue stream in equity broking and financial services, especially significant given Transchem's standalone zero core operating revenue in FY26.
Acquisition Consideration: ₹25.91 CrPer Share Consideration: ₹16.70Target Net Worth (FY26): ₹21.32 CrTarget Turnover (FY26): ₹5.98 CrConsideration vs Net Worth: ~30.8%
📅 Short termPositive sentiment driver as the company deploys idle cash into an operating financial services subsidiary with cleared regulatory approvals.
📈 Long termEnables business diversification away from legacy trading operations, but performance will depend on navigating cyclicality and competition in the broking sector.
⚠ Risk flags
- Target's turnover declined 47% YoY from ₹11.32 Cr in FY25 to ₹5.98 Cr in FY26
- Execution and integration risk in entering a completely new, regulated industry
Key Highlights
Acquired 100% equity (1,55,16,000 shares) of Greshma Shares and Stocks Limited for ₹25.91 Cr in cash at ₹16.70 per share
GSSL reported FY26 turnover of ₹5.98 Cr and net worth of ₹21.32 Cr as of March 31, 2026
Acquisition value of ₹25.91 Cr represents ~30.8% of Transchem's net worth of ₹84 Cr
Full regulatory clearances obtained from SEBI, NSE, BSE, CDSL, NCL, and ICCL prior to execution
👀 What to Watch
Track the integration of GSSL and its consolidation in Transchem's quarterly financials to monitor operational revenue growth and margin contribution.
Transchem Acquires 100% of Greshma Shares & Stocks for ₹25.91 Cr
Transchem Limited has completed the 100% equity acquisition of Greshma Shares and Stocks Limited (GSSL) for an aggregate cash consideration of ₹25.91 crore at ₹16.70 per share. GSSL is a SEBI-registered stockbroker and CDSL depository participant with an FY26 turnover of ₹5.98 crore and a net worth of ₹21.32 crore. All regulatory clearances from SEBI, NSE, BSE, CDSL, and clearing corporations have been obtained, making GSSL a wholly-owned subsidiary. The acquisition marks a major strategic pivot into financial services for Transchem, which reported ₹0 crore standalone TTM revenue.
Confidence: HIGH
What changedTranschem completed the 100% cash buyout of Greshma Shares and Stocks Limited, turning it into a wholly-owned subsidiary.
Why it mattersDeploys ~31% of Transchem's net worth (₹84 Cr) into an operating financial services business, providing an operating revenue base to a company with zero TTM revenue.
Acquisition cost: ₹25.91 crAcquisition cost vs Net worth: ~30.8%Target Net worth (31-Mar-2026): ₹21.32 crTarget FY26 turnover: ₹5.98 crAcquisition price per share: ₹16.70Shares acquired: 1,55,16,000
📅 Short termClear positive clarity as all regulatory clearances are complete and the business will start contributing to consolidated financials immediately.
📈 Long termRepresents a structural business diversification into broking and depository services; long-term value creation will depend on scaling client acquisition and fee-based revenue.
⚠ Risk flags
- Target company revenue declined from ₹11.32 crore in FY25 to ₹5.98 crore in FY26
- Integration and regulatory compliance risks associated with SEBI-regulated capital market intermediaries
- Inherent cyclicality in retail broking and equity market trading volumes
Key Highlights
Acquired 100% equity stake (1,55,16,000 shares) in GSSL for an aggregate consideration of ₹25.91 crore
Cash acquisition executed at ₹16.70 per share, making GSSL a wholly-owned subsidiary effective August 17, 2026
Target company reported FY26 turnover of ₹5.98 crore and net worth of ₹21.32 crore as of March 31, 2026
GSSL turnover stood at ₹11.32 crore in FY25 and ₹9.47 crore in FY24
All regulatory approvals secured, including final SEBI approval on June 19, 2026
👀 What to Watch
Track consolidated financial statements in subsequent quarters to evaluate revenue contribution and operating margins from the newly acquired stockbroking business.
Transchem Q1 Net Profit up 244% to ₹3.42 Cr; ₹115 Cr raised via warrants
Transchem reported zero operational revenue for the quarter ended June 30, 2026, with its entire ₹5.11 Cr income coming from 'Other Income'. Despite the lack of core operations, Net Profit surged 244% YoY to ₹3.42 Cr. The most significant development is the receipt of ₹115.31 Cr as a 25% upfront payment for 6.15 Cr warrants issued at ₹75 each. This upfront cash alone represents approximately 137% of the company's previous net worth of ₹84 Cr.
Confidence: HIGH
What changedThe company has secured a massive capital infusion through warrants while its core operational revenue remains non-existent.
Why it mattersThe total warrant value of ₹461 Cr is a transformative amount for a company with a ₹380 Cr market cap and zero revenue, suggesting a potential pivot or major expansion.
Net Profit (Q1): ₹3.42 CrUpfront Fundraise: ₹115.31 CrUpfront Fundraise vs Net Worth: ~137%Total Warrant Value: ₹461.25 CrRevenue from Operations: ₹0.00
📅 Short termPositive sentiment is expected due to the large cash infusion and YoY profit growth, though the lack of core revenue remains a fundamental weakness.
📈 Long termThe long-term trajectory depends entirely on the effective deployment of the ₹461 Cr total warrant proceeds into revenue-generating assets.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Zero operational revenue
- Massive equity dilution from 6.15 Cr warrants
- Reliance on non-operating income
Key Highlights
Net Profit increased 244% YoY to ₹3.42 Cr from ₹0.99 Cr in June 2025.
Revenue from operations remained at ₹0.00 for the fifth consecutive quarter.
Received ₹115.31 Cr as 25% upfront consideration for 6.15 Cr warrants issued to non-promoters.
Total potential fundraise from warrant conversion stands at ₹461.25 Cr, exceeding the current market cap of ₹380 Cr.
Diluted EPS fell to ₹0.57 (from basic EPS of ₹2.79) due to the massive potential dilution from warrants.
👀 What to Watch
Investors should closely monitor the company's deployment of the ₹115 Cr+ cash and any announcements regarding new business lines, as the current trading business (Soya/Baggase) shows zero activity.
Transchem Q1 PAT at ₹3.42 Cr; Receives ₹115 Cr Upfront from ₹461 Cr Warrant Issue
Transchem reported a net profit of ₹3.42 Cr for Q1 FY27, driven entirely by other income as operational revenue remained at zero. The company has received ₹115.31 Cr as a 25% upfront payment for 6.15 crore warrants issued at ₹75 each to non-promoters. This total fundraise of ₹461.25 Cr is highly material, representing approximately 121% of the company's current market cap. However, the eventual conversion of these warrants will lead to a massive equity dilution, increasing the share count by approximately 500%.
Confidence: HIGH
What changedThe company has successfully initiated a massive fundraise through preferential warrants and reported a jump in net profit solely through other income.
Why it mattersThe fundraise is larger than the company's entire market capitalization, suggesting a potential major business pivot or expansion, though the current lack of operational revenue makes it a high-risk situation.
Total Fundraise Value: ₹461.25 CrFundraise vs Market Cap: ~121%Upfront Cash Received: ₹115.31 CrQ1 Revenue from Operations: ₹0.00Q1 Net Profit: ₹3.42 Cr
📅 Short termThe stock may see volatility due to the large cash infusion, but the lack of operational revenue remains a fundamental overhang.
📈 Long termThe long-term trajectory depends entirely on how the company utilizes the ₹461 Cr; the massive dilution will require significant profit growth to sustain current valuations.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Zero operational revenue
- Massive equity dilution (5x increase in share count)
- Reliance on other income for profitability
Key Highlights
Net Profit increased 244% YoY to ₹3.42 Cr from ₹0.99 Cr in the previous year's quarter.
Revenue from operations remains at ₹0.00 for the quarter ended June 30, 2026.
Received ₹115.31 Cr upfront for 6.15 crore warrants issued at ₹75 per warrant.
Total potential fundraise of ₹461.25 Cr is significantly higher than the current net worth of ₹84 Cr.
Diluted EPS stands at ₹0.57 compared to Basic EPS of ₹2.79, reflecting the massive potential dilution from warrants.
👀 What to Watch
Investors should closely monitor the company's deployment of the ₹461 Cr capital, as the core business currently generates zero revenue. The massive equity dilution upon warrant conversion is a critical factor for valuation.
Transchem Ltd to Acquire Greshma Shares & Stocks; Pivots to Financial Services
Transchem Ltd's FY2025-26 Annual Report confirms a strategic pivot from commodity trading to financial services. The company has received in-principle approval to acquire 100% of Greshma Shares & Stocks Limited and has amended its Memorandum of Association to include securities broking and investment advisory. Despite reporting zero revenue for the TTM period, the company maintains a debt-free balance sheet with a net worth of ₹84 Cr and a massive current ratio of 257.85. Shareholders will vote on these developments and material related party transactions with Crest Ventures at the AGM on September 05, 2026.
Confidence: HIGH
What changedThe company is transitioning from trading Soya and Baggase to becoming a financial services entity through a 100% acquisition and a change in its constitutional business objects.
Why it mattersThis is a total business model pivot for a company with zero current revenue but significant cash reserves, representing a high-risk, high-reward structural change.
Proposed Acquisition Stake: 100%Net Worth: ₹84 CrTTM Revenue: ₹0 CrCurrent Ratio: 257.85Net Profit (FY26): ₹4.3 Cr
📅 Short termNeutral as the market processes the AGM notice and the details of the related party transactions with Crest Ventures.
📈 Long termThe long-term outlook depends entirely on the successful integration of the acquisition and the ability to generate margins in the competitive financial services sector.
⚠ Risk flags
- Zero operational revenue in TTM
- Execution risk in a new business segment
- Material related party transactions with Crest Ventures
- High P/E of 89.8 despite lack of revenue
Key Highlights
Proposed 100% equity acquisition of Greshma Shares & Stocks Limited to enter financial services
Amendment of Objects Clause to include securities broking, portfolio management, and research analytics
Net worth stood at ₹84 Cr as of March 2026 with zero debt (D/E of 0.00)
Exceptionally high Current Ratio of 257.85 indicates significant underutilized liquidity
AGM scheduled for September 05, 2026, with a cut-off date of August 29, 2026, for e-voting
👀 What to Watch
Investors should monitor the completion timeline of the Greshma acquisition and the subsequent activation of the new financial services business, as the company currently lacks operational revenue.
Transchem Ltd Schedules 49th AGM; Seeks Approval for Material RPT and Financial Services Pivot
Transchem has scheduled its 49th AGM for September 5, 2026, to adopt FY26 results and seek approval for a material related party transaction with Crest Ventures Limited. The company is undergoing a significant structural shift, having amended its objects clause to enter financial services and securities broking. A key focus is the pending 100% acquisition of Greshma Shares & Stocks Limited, which was approved in principle in October 2025. Despite reporting zero operational revenue for FY26, the company maintained a PAT of ₹4.3 cr, supported by a strong net worth of ₹84 cr.
Confidence: HIGH
What changedThe company is formalizing its transition from commodity trading to financial services and seeking shareholder approval for related party transactions and director re-appointments.
Why it mattersWith the legacy trading business generating zero revenue, the successful acquisition and integration of a brokerage firm is the primary driver for future value creation.
FY26 Revenue: ₹0.0 crFY26 Net Profit: ₹4.3 crNet Worth: ₹84 crAcquisition Stake: 100%Net Worth Growth (FY25): 4.85%
📅 Short termThe stock may remain volatile as investors digest the transition from a dormant trading entity to a financial services player.
📈 Long termThe long-term outlook depends entirely on the execution of the new financial services strategy and the profitability of the acquired entity.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Zero operational revenue in current business
- Execution risk in entering a highly competitive financial services sector
- High P/E ratio of 89.8 relative to zero revenue
Key Highlights
49th Annual General Meeting scheduled for September 5, 2026, via Video Conferencing
Pending 100% equity acquisition of Greshma Shares & Stocks Limited as part of a strategic pivot
FY26 Net Profit of ₹4.3 cr reported despite ₹0.0 cr operational revenue
Book closure period set from August 30, 2026, to September 5, 2026
Amendment of Memorandum of Association to include securities broking and investment advisory services
👀 What to Watch
Monitor the completion timeline of the Greshma Shares & Stocks acquisition and the subsequent activation of the financial services business to address the current zero-revenue status.
